Home » Topics » BioWorld Science

BioWorld Science
RSS

GLP-1R agonist PF-1801 seen useful to treat polymyositis

July 8, 2022

DS-17701585, EP300/CBP inhibitor with efficacy in lung squamous cell carcinoma xenograft

July 8, 2022

Aramchol shows effects in preclinical models of lung and gastrointestinal fibrosis

July 8, 2022

Explant glioblastoma model may allow early precision treatment of patients

July 8, 2022

Novel vaccination strategy using AMP-CpG against EBV infection shows promise in vivo

July 8, 2022

New ROCK-1/2 inhibitors identified at Chiesi Farmaceutici

July 8, 2022

Shanghai Institute of Materia Medica describes thyroid hormone receptor agonists

July 8, 2022

New pantetheinase inhibitors discovered at Shanghai Meiyue Biotech Development

July 8, 2022

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present SLC9A3 inhibitors

July 8, 2022

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical patents ADCs targeting B7-H3

July 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...